Proteomic insights into chronic anthracycline cardiotoxicity.
about
The tell-tale heart: molecular and cellular responses to childhood anthracycline exposureMitoxantrone-Surfactant Interactions: A Physicochemical OverviewMolecular remodeling of left and right ventricular myocardium in chronic anthracycline cardiotoxicity and post-treatment follow up.Modulation of caveolins, integrins and plasma membrane repair proteins in anthracycline-induced heart failure in rabbits.Mitochondrial proteome remodeling in ischemic heart failureCardioprotective role of P38 MAPK during myocardial infarction via parallel activation of α-crystallin B and Nrf2.Analysis of mtDNA, miR-155 and BACH1 expression in hearts from donors with and without Down syndrome.Proteomic remodeling of mitochondria in heart failureProteostasis and REDOX state in the heart.The Alpha-1A Adrenergic Receptor in the Rabbit Heart.An Alpha-1A Adrenergic Receptor Agonist Prevents Acute Doxorubicin Cardiomyopathy in Male Mice.Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly(butylcyanoacrylate) nanoparticles.An Upgrade on the Rabbit Model of Anthracycline-Induced Cardiomyopathy: Shorter Protocol, Reduced Mortality, and Higher Incidence of Overt Dilated Cardiomyopathy.Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection.Pharmacogenomics as a risk mitigation strategy for chemotherapeutic cardiotoxicity.Cardiac systolic dysfunction in doxorubicin-challenged rats is associated with upregulation of MuRF2 and MuRF3 E3 ligasesCardiotoxicity of anthracycline therapy: current perspectivesCardiac side effects of anticancer treatments: new mechanistic insightsSystems biology approaches to adverse drug effects: the example of cardio-oncology.Anticancer effects of cantharidin in A431 human skin cancer (Epidermoid carcinoma) cells in vitro and in vivo.Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone.Mitochondria death/survival signaling pathways in cardiotoxicity induced by anthracyclines and anticancer-targeted therapies.Toxicoproteomics in human health and disease: an update.GCN2 deficiency ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and myocardial oxidative stress.
P2860
Q26823592-7280F4BC-9B59-4654-A070-CCAB227D33EAQ28066259-6C159836-E4E0-4388-8472-D26AF6DC1F94Q33578496-7975CADB-70DE-4D6D-8427-6F991A11F727Q33675082-EE7DBE5C-A915-4912-9E6D-BBA547971C55Q33822885-F71092E1-0D10-4EFC-9337-C6194CEFA6F8Q34400162-13116FFE-281B-422A-9AA2-891317F74FF3Q35044480-4FFA3388-426F-46F6-BA68-5732698F5644Q35588455-F557310D-B5AD-48EC-B542-D2D103E22CC2Q35906430-A1CF99F3-DA3A-4D38-9B6C-61C5B5B8FF0FQ36039856-C4408903-7E84-4ADC-AEE9-C51F5D5D5C2AQ36247553-48F26CD0-B812-46D0-A11D-2D51FC5617EAQ36390679-DD25C756-3767-4587-B3BE-0059F1B6F952Q36415905-0AC4E0AD-E368-4F76-B20C-49868F9C289CQ36568908-1720D6CB-F2E5-45A9-92B8-F5FD6BE856D8Q36637796-F2CED39A-4FD0-48B0-A127-05AC06E0021DQ36772298-D52F7502-7942-457B-84D8-DC36C7ADABDBQ36845348-6081DFAE-D831-4660-BD2D-BBA1A0195D34Q36957758-1820405B-4499-4D6A-9871-44CDD33270CEQ38606067-D4F93772-4245-4B5B-A9D2-19F43CA79858Q38775407-4C7E83CC-8B09-4A54-976C-34828CB6EA6BQ38876257-EEC29FF5-E04B-4447-BC5C-3B3A82A22479Q42559258-F6063012-FE0D-47BC-9C8E-73C1B175B57FQ51344755-92ABDCF7-964F-4C45-8FEE-A65AEC60A2ECQ54115847-5F98B53B-BAD2-4CAE-9942-0B5E179DFE33
P2860
Proteomic insights into chronic anthracycline cardiotoxicity.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Proteomic insights into chronic anthracycline cardiotoxicity.
@en
Proteomic insights into chronic anthracycline cardiotoxicity.
@nl
type
label
Proteomic insights into chronic anthracycline cardiotoxicity.
@en
Proteomic insights into chronic anthracycline cardiotoxicity.
@nl
prefLabel
Proteomic insights into chronic anthracycline cardiotoxicity.
@en
Proteomic insights into chronic anthracycline cardiotoxicity.
@nl
P2093
P50
P1476
Proteomic insights into chronic anthracycline cardiotoxicity
@en
P2093
Alena Fučíková
Eva Brčáková
Martin Stěrba
Olga Popelová
Vladimír Geršl
Yvona Mazurová
P304
P356
10.1016/J.YJMCC.2011.01.018
P577
2011-01-31T00:00:00Z